M, R. T. (2023). Viral Induced Coagulopathy: A Formidable Foe or a Benevolent Friend. Vaccines & Vaccination Open Access, 8(1), 1–4. https://doi.org/10.23880/vvoa-16000158

Kumar, A., Asghar, A., Singh, H. N., Faiq, M. A., Kumar, S., Narayan, R. K., Kumar, G., Dwivedi, P., Sahni, C., Jha, R. K., Kulandhasamy, M., Prasoon, P., Sesham, K., Kant, K., & Pandey, S. N. (2023). SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis. JMIR Bioinformatics and Biotechnology, 4, e42700. https://doi.org/10.2196/42700

Stockwell, M. S., Porucznik, C. A., Dixon, A., Duque, J., Stanford, J. B., Veguilla, V., & Dawood, F. S. (2022). Factors Associated with Intention to Vaccinate Children 0-11 Years of Age Against COVID-19. The Journal of the American Board of Family Medicine, 35(6), 1174–1178. https://doi.org/10.3122/jabfm.2022.220150r1

Guzman, C. P., Aron, J., Egbebike, J., Greene, M. C., Reisig, C., DeFilippo, M., Bollman, E. B., Stefan, B. R., Chang, B. P., Wagh, A., & Firew, T. (2022). COVID‐19 vaccine controversy: A cross‐sectional analysis of factors associated with COVID‐19 vaccine acceptance amongst emergency department patients in New York City. Journal of the American College of Emergency Physicians Open, 3(6). Portico. https://doi.org/10.1002/emp2.12830

Liu, H., Iketani, S., Zask, A., Khanizeman, N., Bednarova, E., Forouhar, F., Fowler, B., Hong, S. J., Mohri, H., Nair, M. S., Huang, Y., Tay, N. E. S., Lee, S., Karan, C., Resnick, S. J., Quinn, C., Li, W., Shion, H., Xia, X., … Stockwell, B. R. (2022). Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-29413-2

Wang, P., Casner, R. G., Nair, M. S., Yu, J., Guo, Y., Wang, M., Chan, J. F.-W., Cerutti, G., Iketani, S., Liu, L., Sheng, Z., Chen, Z., Yuen, K.-Y., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses. Emerging Microbes & Infections, 11(1), 147–157. https://doi.org/10.1080/22221751.2021.2011623

Laise, P., Stanifer, M. L., Bosker, G., Sun, X., Triana, S., Doldan, P., La Manna, F., De Menna, M., Realubit, R. B., Pampou, S., Karan, C., Alexandrov, T., Kruithof-de Julio, M., Califano, A., Boulant, S., & Alvarez, M. J. (2022). A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection. Communications Biology, 5(1). https://doi.org/10.1038/s42003-022-03663-8

Tanaka, J., Senpuku, H., Ogawa, M., Yasuhara, R., Ohnuma, S., Takamatsu, K., Watanabe, T., Mabuchi, Y., Nakamura, S., Ishida, S., Sadaoka, T., Takaki, T., Shirota, T., Shimane, T., Inoue, T., Sakai, T., Mori, M., Tsuji, T., Saito, I., & Mishima, K. (2022). Human induced pluripotent stem cell-derived salivary gland organoids model SARS-CoV-2 infection and replication. Nature Cell Biology, 24(11), 1595–1605. https://doi.org/10.1038/s41556-022-01007-6

Zeijlon, R., Hällgren, P., Le, V., Chamat, J., Wågerman, J., Enabtawi, I., Rawshani, A., Unenge, S., Jha, S., Omerovic, E., & Redfors, B. (2022). The role of admission electrocardiogram in predicting outcome in patients hospitalized for COVID-19. Journal of Electrocardiology, 75, 10–18. https://doi.org/10.1016/j.jelectrocard.2022.10.005

Hedvat, J., Lange, N. W., Salerno, D. M., DeFilippis, E. M., Kovac, D., Corbo, H., Chen, J. K., Choe, J. Y., Lee, J. H., Anamisis, A., Jennings, D. L., Codispodo, G., Shertel, T., Brown, R. S., & Pereira, M. R. (2022). COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era. American Journal of Transplantation, 22(11), 2682–2688. https://doi.org/10.1111/ajt.17140

Miller, C. N., Althoff, K. N., Schlueter, D. J., Anton-Culver, H., Chen, Q., Garbett, S., Ratsimbazafy, F., Thomsen, I., Karlson, E. W., Cicek, M., Pinto, L. A., Malin, B. A., Ohno-Machado, L., Williams, C., Goldstein, D., Kouame, A., Ramirez, A., Gebo, K. A., & Schully, S. D. (2022). Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence. MSphere, 7(5). https://doi.org/10.1128/msphere.00257-22

Pinheiro, J. R., dos Reis, E. C., Farias, J. P., Fogaça, M. M. C., da Silva, P. de S., Santana, I. V. R., Rocha, A. L. S., Vidal, P. O., Simões, R. da C., Luiz, W. B., Birbrair, A., de Aguiar, R. S., de Souza, R. P., Azevedo, V. A. de C., Chaves, G., Belmok, A., Durães-Carvalho, R., Melo, F. L., Ribeiro, B. M., & Amorim, J. H. (2022). Impact of Early Pandemic SARS-CoV-2 Lineages Replacement with the Variant of Concern P.1 (Gamma) in Western Bahia, Brazil. Viruses, 14(10), 2314. https://doi.org/10.3390/v14102314

Diray-Arce, J., Miller, H. E. R., Henrich, E., Gerritsen, B., Mulè, M. P., Fourati, S., Gygi, J., Hagan, T., Tomalin, L., Rychkov, D., Kazmin, D., Chawla, D. G., Meng, H., Dunn, P., Campbell, J., Deckhut-Augustine, A., Gottardo, R., Haddad, E. K., … Suárez-Fariñas, M. (2022). The Immune Signatures data resource, a compendium of systems vaccinology datasets. Scientific Data, 9(1). https://doi.org/10.1038/s41597-022-01714-7

Kuznetsova, L., Diago-Navarro, E., Mathu, R., & Trilla, A. (2022). Effectiveness of COVID-19 Vaccination Mandates and Incentives in Europe. Vaccines, 10(10), 1714. https://doi.org/10.3390/vaccines10101714

Iketani, S., Hong, S. J., Sheng, J., Bahari, F., Culbertson, B., Atanaki, F. F., Aditham, A. K., Kratz, A. F., Luck, M. I., Tian, R., Goff, S. P., Montazeri, H., Sabo, Y., Ho, D. D., & Chavez, A. (2022). Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites. Cell Host & Microbe, 30(10), 1354-1362.e6. https://doi.org/10.1016/j.chom.2022.08.003

Ferdinands, J. M., Rao, S., Dixon, B. E., Mitchell, P. K., DeSilva, M. B., Irving, S. A., Lewis, N., Natarajan, K., Stenehjem, E., Grannis, S. J., Han, J., McEvoy, C., Ong, T. C., Naleway, A. L., Reese, S. E., Embi, P. J., Dascomb, K., Klein, N. P., Griggs, E. P., … Fireman, B. (2022). Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study. BMJ, e072141. https://doi.org/10.1136/bmj-2022-072141

Mergenova, G., Rosenthal, S., Zhussupov, B., Izekenova, A., Alekesheva, L., Izekenova, A., Iskakova, B., Myrkassymova, A., Bukharbayeva, A., & Davis, A. (2022). COVID-19 vaccination hesitancy in Kazakhstan. European Journal of Public Health, 32(Supplement_3). https://doi.org/10.1093/eurpub/ckac129.662

Sobieszczyk, M. E., Maaske, J., Falsey, A. R., Sproule, S., Robb, M. L., Frenck, R. W., Tieu, H.-V., Mayer, K. H., Corey, L., Neuzil, K. M., Tong, T., Brewinski Isaacs, M., Janes, H., Bansal, H., Edwards, L. M., Green, J. A., Kelly, E. J., Shoemaker, K., Takas, T., … Hirsch, and I. (2022). Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months. Journal of Clinical Investigation, 132(18). https://doi.org/10.1172/jci160565

Li, T.-W., Kenney, A. D., Park, J.-G., Fiches, G. N., Liu, H., Zhou, D., Biswas, A., Zhao, W., Que, J., Santoso, N., Martinez-Sobrido, L., Yount, J. S., & Zhu, J. (2022). SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1007089

de Souza, M. O., Madan, B., Teng, I.-T., Huang, A., Liu, L., Fahad, A. S., Lopez Acevedo, S. N., Pan, X., Sastry, M., Gutierrez-Gonzalez, M., Yin, M. T., Zhou, T., Ho, D. D., Kwong, P. D., & DeKosky, B. J. (2022). Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.977064

Mathema, B., Chen, L., Wang, P., Cunningham, M. H., Mediavilla, J. R., Chow, K. F., Luo, Y., Zhao, Y., Composto, K., Zuckerman, J., Zody, M. C., Wilson, N., Lee, A., Oschwald, D. M., Liu, L., Iketani, S., Germer, S., Fennessey, S., Wang, M., … Kreiswirth, B. N. (2022). Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey. MBio, 13(5). https://doi.org/10.1128/mbio.02141-22

Lonze, B. E., Spiegler, P., Wesson, R. N., Alachkar, N., Petkova, E., Weldon, E. P., Dieter, R. A., Li, Y., Quinn, M., Mattoo, A., Soomro, I., Cohen, S. M., Leung, S., Deterville, C. L., Landrum, B. M., Ali, M. I., Cohen, D. J., Singer, A. L., Sen, A., … Montgomery, R. A. (2022). A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation*. Critical Care Medicine, 50(9), 1348–1359. https://doi.org/10.1097/ccm.0000000000005591

Chang, C., Vlad, G., Vasilescu, E. R., Li, P., Husain, S. A., Silvia, E. A., Cohen, D. J., Ratner, L. E., Sun, W., Mohan, S., & Suciu‐Foca, N. (2022). Previous SARS‐CoV‐2 infection or a third dose of vaccine elicited cross‐variant neutralising antibodies in vaccinated solid‐organ transplant recipients. Clinical & Translational Immunology, 11(8). Portico. https://doi.org/10.1002/cti2.1411

Gkioulekas, E., McCullough, P. A., & Zelenko, V. (2022). Statistical Analysis Methods Applied to Early Outpatient COVID-19 Treatment Case Series Data. COVID, 2(8), 1139–1182. https://doi.org/10.3390/covid2080084

Leuva, H., Zhou, M., Brau, N., Brown, S. T., Mundi, P., Rosenberg, T.-C. M., Luhrs, C., Bates, S. E., Park, Y.-H. A., & Fojo, T. (2022). Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans. Seminars in Oncology, 49(5), 363–370. https://doi.org/10.1053/j.seminoncol.2022.07.005

Sumner, K. M., Karron, R. A., Stockwell, M. S., Dawood, F. S., Stanford, J. B., Mellis, A., Hacker, E., Thind, P., Castro, M. J. E., Harris, J. P., Deloria Knoll, M., Schappell, E., Hetrich, M. K., Duque, J., Jeddy, Z., Altunkaynak, K., Poe, B., Meece, J., Stefanski, E., … Woods, S. (2022). Impact of Age and Symptom Development on SARS-CoV-2 Transmission in Households With Children—Maryland, New York, and Utah, August 2020–October 2021. Open Forum Infectious Diseases, 9(8). https://doi.org/10.1093/ofid/ofac390

Ostropolets, A., & Hripcsak, G. (2022). COVID-19 vaccination effectiveness rates by week and sources of bias: a retrospective cohort study. BMJ Open, 12(8), e061126. https://doi.org/10.1136/bmjopen-2022-061126

Shah, N. J., Patel, V. G., Zhong, X., Pina, L., Hawley, J. E., Lin, E., Gartrell, B. A., Febles, V. A., Wise, D. R., Qin, Q., Mellgard, G., Joshi, H., Nauseef, J. T., Green, D. A., Vlachostergios, P. J., Kwon, D. H., Huang, F., Liaw, B., Tagawa, S., … Oh, W. K. (2022). The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer. JNCI Cancer Spectrum, 6(3). https://doi.org/10.1093/jncics/pkac035

Sania, A., Alam, A. N., Alamgir, A. S. M., Andrecka, J., Brum, E., Chadwick, F., Chowdhury, T., Hasan, Z., Hill, D. L., Khan, F., Kundegorski, M., Lee, S., Rahman, M., Rayport, Y. K., Shirin, T., Tasneem, M., & Hampson, K. (2022). Rapid antigen testing by community health workers for detection of SARS-CoV-2 in Dhaka, Bangladesh: a cross-sectional study. BMJ Open, 12(6), e060832. https://doi.org/10.1136/bmjopen-2022-060832

Ozdede, A., Guner, S., Ozcifci, G., Yurttas, B., Toker Dincer, Z., Atli, Z., Uygunoğlu, U., Durmaz, E., Uçar, D., Uğurlu, S., Saip, S., Tabak, F., Hamuryudan, V., & Seyahi, E. (2022). Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine. Rheumatology International, 42(6), 973–987. https://doi.org/10.1007/s00296-022-05119-y

Ostropolets, A., Ryan, P. B., Schuemie, M. J., & Hripcsak, G. (2022). Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study. JMIR Public Health and Surveillance, 8(6), e33099. https://doi.org/10.2196/33099

Liu, L., Iketani, S., Guo, Y., Reddem, E. R., Casner, R. G., Nair, M. S., Yu, J., Chan, J. F.-W., Wang, M., Cerutti, G., Li, Z., Morano, N. C., Castagna, C. D., Corredor, L., Chu, H., Yuan, S., Poon, V. K.-M., Chan, C. C.-S., Chen, Z., … Ho, D. D. (2022). An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses. Science Translational Medicine, 14(646). https://doi.org/10.1126/scitranslmed.abn6859

Ozdede, A., Güner, S., Ozcifci, G., Yurttas, B., Toker Dincer, Z., Atli, Z., Uygunoglu, U., Durmaz, E., Ucar, D., Ugurlu, S., Saip, S., Tabak, Ö. F., Hamuryudan, V., & Seyahi, E. (2022). POS1255 SAFETY OF THE PFIZER/BIONTECH AND SINOVAC/CORONAVAC VACCINES AMONG PATIENTS WITH BEHCET’S SYNDROME AND FAMILIAL MEDITERRANEAN FEVER. Annals of the Rheumatic Diseases, 81, 962–963. https://doi.org/10.1136/annrheumdis-2022-eular.3711

Ostropolets, A., Li, X., Makadia, R., Rao, G., Rijnbeek, P. R., Duarte-Salles, T., Sena, A. G., Shaoibi, A., Suchard, M. A., Ryan, P. B., Prieto-Alhambra, D., & Hripcsak, G. (2022). Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.814198

Klouda, T., Hao, Y., Kim, H., Kim, J., Olejnik, J., Hume, A. J., Ayyappan, S., Hong, X., Melero-Martin, J., Fang, Y., Wang, Q., Zhou, X., Mühlberger, E., Jia, H., Padera, R. F., Raby, B. A., & Yuan, K. (2021). Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2. Angiogenesis, 25(2), 225–240. https://doi.org/10.1007/s10456-021-09823-4

Liu, C., Lee, J., Ta, C., Soroush, A., Rogers, J. R., Kim, J. H., Natarajan, K., Zucker, J., Perl, Y., & Weng, C. (2022). Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis. JMIR Public Health and Surveillance, 8(5), e35311. https://doi.org/10.2196/35311

Wolf, J., Abzug, M. J., Anosike, B. I., Vora, S. B., Waghmare, A., Sue, P. K., Olivero, R. M., Oliveira, C. R., James, S. H., Morton, T. H., Maron, G. M., Young, J. L., Orscheln, R. C., Schwenk, H. T., Bio, L. L., Willis, Z. I., Lloyd, E. C., Hersh, A. L., Huskins, C. W., … Nakamura, M. M. (2022). Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents. Journal of the Pediatric Infectious Diseases Society, 11(5), 177–185. https://doi.org/10.1093/jpids/piab124

Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., Sabati, A., Nguyen, H. H., Hussain, T., Khan, D., Parra, D. A., Su, J. A., Patel, J. K., Ronai, C., Bohun, M., Freij, B. J., O’Connor, M. J., Rosanno, J. W., Gupta, A., … Ang, J. Y. (2022). mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. The Journal of Pediatrics, 243, 208-213.e3. https://doi.org/10.1016/j.jpeds.2021.12.025

Brailovsky, Y., Masoumi, A., Bijou, R., Oliveros, E., Sayer, G., Takeda, K., & Uriel, N. (2022). Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation. JACC: Case Reports, 4(5), 265–270. https://doi.org/10.1016/j.jaccas.2021.11.013

Schmidt, A. L., Labaki, C., Hsu, C.-Y., Bakouny, Z., Balanchivadze, N., Berg, S. A., Blau, S., Daher, A., El Zarif, T., Friese, C. R., Griffiths, E. A., Hawley, J. E., Hayes-Lattin, B., Karivedu, V., Latif, T., Mavromatis, B. H., McKay, R. R., Nagaraj, G., Nguyen, R. H., … Warner, J. L. (2022). COVID-19 vaccination and breakthrough infections in patients with cancer. Annals of Oncology, 33(3), 340–346. https://doi.org/10.1016/j.annonc.2021.12.006

Sahajpal, N. S., Jill Lai, C.-Y., Hastie, A., Mondal, A. K., Dehkordi, S. R., van der Made, C. I., Fedrigo, O., Al-Ajli, F., Jalnapurkar, S., Byrska-Bishop, M., Kanagal-Shamanna, R., Levy, B., Schieck, M., Illig, T., Bacanu, S.-A., Chou, J. S., Randolph, A. G., Rojiani, A. M., Zody, M. C., … Kolhe, R. (2022). Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19. IScience, 25(2), 103760. https://doi.org/10.1016/j.isci.2022.103760

Kyaw, H., Shajahan, S., Gulati, A., Synn, S., Khurana, S., Nazar, N., Shrestha, S., & Kerstein, J. (2022). COVID-19 mRNA Vaccine-Associated Myocarditis. Cureus. https://doi.org/10.7759/cureus.21009

Purpura, L. J., Chang, M., Annavajhala, M. K., Mohri, H., Liu, L., Shah, J., Cantos, A., Medrano, N., Laracy, J., Scully, B., Miko, B. A., Habal, M., Pereira, M. R., Tsuji, M., Ho, D. D., Uhlemann, A.-C., & Yin, M. T. (2022). Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient. American Journal of Transplantation, 22(2), 649–653. https://doi.org/10.1111/ajt.16837

Bhatt, A. S., Adler, E. D., Albert, N. M., Anyanwu, A., Bhadelia, N., Cooper, L. T., Correa, A., Defilippis, E. M., Joyce, E., Sauer, A. J., Solomon, S. D., Vardeny, O., Yancy, C., & Lala, A. (2022). Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. Journal of Cardiac Failure, 28(1), 93–112. https://doi.org/10.1016/j.cardfail.2021.08.013

Dawood, F. S., Porucznik, C. A., Veguilla, V., Stanford, J. B., Duque, J., Rolfes, M. A., Dixon, A., Thind, P., Hacker, E., Castro, M. J. E., Jeddy, Z., Daugherty, M., Altunkaynak, K., Hunt, D. R., Kattel, U., Meece, J., & Stockwell, M. S. (2022). Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York. JAMA Pediatrics, 176(1), 59. https://doi.org/10.1001/jamapediatrics.2021.4217

Feghali, E. J., Zafar, M., Abid, S., Santoriello, D., & Mehta, S. (2021). De-Novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 (Moderna) Vaccine for COVID-19. Cureus. https://doi.org/10.7759/cureus.19616

Madan, B., Reddem, E. R., Wang, P., Casner, R. G., Nair, M. S., Huang, Y., Fahad, A. S., de Souza, M. O., Banach, B. B., López Acevedo, S. N., Pan, X., Nimrania, R., Teng, I., Bahna, F., Zhou, T., Zhang, B., Yin, M. T., Ho, D. D., Kwong, P. D., … DeKosky, B. J. (2021). Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV‐2. AIChE Journal, 67(12). Portico. https://doi.org/10.1002/aic.17440

Ranard, B. L., Megjhani, M., Terilli, K., Doyle, K., Claassen, J., Pinsky, M. R., Clermont, G., Vodovotz, Y., Asgari, S., & Park, S. (2021). Identification of Endotypes of Hospitalized COVID-19 Patients. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.770343

Ferren, M., Favède, V., Decimo, D., Iampietro, M., Lieberman, N. A. P., Weickert, J.-L., Pelissier, R., Mazelier, M., Terrier, O., Moscona, A., Porotto, M., Greninger, A. L., Messaddeq, N., Horvat, B., & Mathieu, C. (2021). Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-26096-z

Dube, G. K., Benvenuto, L. J., & Batal, I. (2021). Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine. Kidney International Reports, 6(12), 3087–3089. https://doi.org/10.1016/j.ekir.2021.08.012